Atea Pharmaceuticals Inc. (AVIR)
NASDAQ · Healthcare
Atea Pharmaceuticals Inc. Income Statement 2020–2021
| Dec 2021 | Dec 2020 | |
|---|---|---|
| Revenues | ||
| Revenue | 351.4M | 48.6M |
| Gross Profit | — | — |
| Profitability | ||
| Operating Income | 138.4M | -11.0M |
| EBITDA | 138.4M | -11.0M |
| Net Income | 121.2M | -10.9M |
| Per Share Data | ||
| EPS (diluted) | — | — |
| Shares Outstanding (dil.) | 88M | 22M |
Atea Pharmaceuticals Inc. Income Statement — FAQ
Atea Pharmaceuticals Inc. (AVIR) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVIR's income statement history?
The chart and table above show Atea Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.